Ochre Bio

Developer of ribonucleic acid therapies for treating chronic liver diseases

placeOxford, England, United Kingdom calendar_todayFounded 2019 groups11 employees language ochre-bio.com

Registered entities

Social engagement

Social engagement: 11.9K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

23 investors on record; lead investors include Khosla Ventures, Y Combinator.

Investor typeCountShare
Venture capital1252%
Accelerator & incubator29%
Bank & private debt14%
Other / undisclosed835%
Coming soon